206 related articles for article (PubMed ID: 25148170)
1. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM
AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
[TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis is associated with increased hepatic FDG uptake.
Keramida G; Potts J; Bush J; Dizdarevic S; Peters AM
Eur J Radiol; 2014 May; 83(5):751-5. PubMed ID: 24581596
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
Keramida G; Hunter J; Dizdarevic S; Peters AM
Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891
[TBL] [Abstract][Full Text] [Related]
4. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
[TBL] [Abstract][Full Text] [Related]
5. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
6. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
Abele JT; Fung CI
Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
[TBL] [Abstract][Full Text] [Related]
7. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG uptake and clearance in patients with compromised renal function.
Akers SR; Werner TJ; Rubello D; Alavi A; Cheng G
Nucl Med Commun; 2016 Aug; 37(8):825-32. PubMed ID: 27058366
[TBL] [Abstract][Full Text] [Related]
9. Is liver SUV stable over time in ¹⁸F-FDG PET imaging?
Laffon E; Adhoute X; de Clermont H; Marthan R
J Nucl Med Technol; 2011 Dec; 39(4):258-63. PubMed ID: 21878481
[TBL] [Abstract][Full Text] [Related]
10. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT.
Abikhzer G; Alabed YZ; Azoulay L; Assayag J; Rush C
AJR Am J Roentgenol; 2011 Jan; 196(1):176-80. PubMed ID: 21178064
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.
Dostbil Z; Varoğlu E; Serdengeçti M; Kaya B; Onder H; Sari O
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):156-61. PubMed ID: 23177332
[TBL] [Abstract][Full Text] [Related]
12. Hepatic and splenic
Keramida G; Roldao Pereira L; Kaya G; Peters AM
Clin Physiol Funct Imaging; 2020 Mar; 40(2):99-105. PubMed ID: 31769591
[TBL] [Abstract][Full Text] [Related]
13. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
15. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
[TBL] [Abstract][Full Text] [Related]
16. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
Iozzo P; Jarvisalo MJ; Kiss J; Borra R; Naum GA; Viljanen A; Viljanen T; Gastaldelli A; Buzzigoli E; Guiducci L; Barsotti E; Savunen T; Knuuti J; Haaparanta-Solin M; Ferrannini E; Nuutila P
Gastroenterology; 2007 Feb; 132(2):531-42. PubMed ID: 17258736
[TBL] [Abstract][Full Text] [Related]
17. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
18. Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
Keramida G; Dizdarevic S; Bush J; Peters AM
Eur Radiol; 2015 Sep; 25(9):2701-8. PubMed ID: 25899414
[TBL] [Abstract][Full Text] [Related]
19. Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
Hong SP; Noh TS; Moon SH; Cho YS; Lee EJ; Choi JY; Kim BT; Lee KH
Dig Dis Sci; 2014 Mar; 59(3):607-13. PubMed ID: 24326630
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI.
Seraj SM; Al-Zaghal A; Zadeh MZ; Jahangiri P; Pournazari K; Raynor WY; Werner TJ; Høilund-Carlsen PF; Alavi A; Hunt SJ
Nucl Med Commun; 2019 May; 40(5):545-551. PubMed ID: 30807535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
